Stat5 activation plays a critical role in Th2 differentiation

Immunity

Volumn 19, Issue 5, 2003, Pages 739-748

  Zhu, Jinfang ^a   Cote Sierra, Javier ^a   Guo, Liying ^a   Paul, William E ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; ISOPROTEIN; MUTANT PROTEIN; NERVE GROWTH FACTOR RECEPTOR; PROTEIN SUBUNIT; RESTRICTION ENDONUCLEASE; STAT5 PROTEIN; STAT6 PROTEIN; TRANSCRIPTION FACTOR GATA 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESTRICTION SITE; RETROVIRUS; RETROVIRUS INFECTION; T LYMPHOCYTE; TH2 CELL;

EID: 0344064893     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(03)00292-9     Document Type: Article

References (42)

1. Agarwal S., Rao A. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity. 9:1998;765-775.
2. Agarwal S., Avni O., Rao A. Cell-type-restricted binding of the transcription factor NFAT to a distal IL-4 enhancer in vivo. Immunity. 12:2000;643-652.
3. Ariyoshi K., Nosaka T., Yamada K., Onishi M., Oka Y., Miyajima A., Kitamura T. Constitutive activation of STAT5 by a point mutation in the SH2 domain. J. Biol. Chem. 275:2000;24407-24413.
4. Auernhammer C.J., Bousquet C., Melmed S. Autoregulation of pituitary corticotroph SOCS-3 expression. characterization of the murine SOCS-3 promoter Proc. Natl. Acad. Sci. USA. 96:1999;6964-6969.
5. Ben-Sasson S.Z., Le Gros G., Conrad D.H., Finkelman F.D., Paul W.E. IL-4 production by T cells from naïve donors. IL-2 is required for IL-4 production. J. Immunol. 145:1990;1127-1136.
6. Boer A.K., Drayer A.L., Rui H., Vellenga E. Prostaglandin-E-2 enhances EPO-mediated STAT5 transcriptional activity by serine phosphorylation of CREB. Blood. 100:2002;467-473.
7. Finkelman F.D., Morris S.C., Orekhova T., Mori M., Donaldson D., Reiner S.L., Reilly N.L., Schopf L., Urban J.F. Jr. Stat6 regulation of in vivo IL-4 responses. J. Immunol. 164:2000;2303-2310.
8. Guo L., Hu-Li J., Zhu J., Watson C.J., Difilippantonio M.J., Pannetier C., Paul W.E. In TH2 cells the Il4 gene has a series of accessibility states associated with distinctive probabilities of IL-4 production. Proc. Natl. Acad. Sci. USA. 99:2002;10623-10628.
9. Hinz M., Lemke P., Anagnostopoulos I., Hacker C., Krappmann D., Mathas S., Dorken B., Zenke M., Stein H., Scheidereit C. Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J. Exp. Med. 196:2002;605-617.
10. Hural J.A., Kwan M., Henkel G., Hock M.B., Brown M.A. An intron transcriptional enhancer element regulates IL-4 gene locus accessibility in mast cells. J. Immunol. 165:2000;3239-3249.
11. Jankovic D., Kullberg M.C., Noben-Trauth N., Caspar P., Paul W.E., Sher A. Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4(+) lymphocytes with a Th2 cytokine profile. J. Immunol. 164:2000;3047-3055.
12. Kagami S., Nakajima H., Kumano K., Suzuki K., Suto A., Imada K., Davey H.W., Saito Y., Takatsu K., Leonard W.J., Iwamoto I. Stat5a and Stat5b are required for antigen-induced eosinophil and T-cell recruitment into the tissue. Blood. 95:2000;1370-1377.
13. Kagami S., Nakajima H., Suto A., Hirose K., Suzuki K., Morita S., Kato I., Saito Y., Kitamura T., Iwamoto I. Stat5A regulates T helper cell differentiation by several distinct mechanisms. Blood. 97:2001;2358-2365.
14. Kaplan M.H., Schindler U., Smiley S.T., Grusby M.J. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity. 4:1996;313-319.
15. Kishikawa H., Sun J., Choi A., Miaw S.C., Ho I.C. The cell type-specific expression of the murine il-13 gene is regulated by Gata-3. J. Immunol. 167:2001;4414-4420.
16. Le Gros G., Ben-Sasson S.Z., Seder R., Finkelman F.D., Paul W.E. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro. IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells J. Exp. Med. 172:1990;921-929.
17. Lin J.X., Leonard W.J. The role of Stat5A and Stat5B in signaling by IL-2 family cytokines. Oncogene. 19:2000;2566-2576.
18. Loots G.G., Locksley R.M., Blankespoor C.M., Wang Z.E., Miller W., Rubin E.M., Frazer K.A. Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science. 288:2000;136-140.
19. Mohrs M., Shinkai K., Mohrs K., Locksley R.M. Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity. 15:2001;303-311. a.
20. Mohrs M., Blankespoor C.M., Wang Z.E., Loots G.G., Afzal V., Hadeiba H., Shinkai K., Rubin E.M., Locksley R.M. Deletion of a coordinate regulator of type 2 cytokine expression in mice. Nat. Immunol. 2:2001;842-847. b.
21. Mora A., Youn J., Keegan A., Boothby M. NF-kappa B/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells. J. Immunol. 166:2001;2218-2227.
22. Moriggl R., Sexl V., Piekorz R., Topham D., Ihle J.N. Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells. Immunity. 11:1999;225-230. a.
23. Moriggl R., Topham D.J., Teglund S., Sexl V., McKay C., Wang D., Hoffmeyer A., van Deursen J., Sangster M.Y., Bunting K.D., et al. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity. 10:1999;249-259. b.
24. Murphy K.M., Reiner S.L. The lineage decisions of helper T cells. Nat. Rev. Immunol. 2:2002;933-944.
25. Murphy K.M., Ouyang W., Farrar J.D., Yang J., Ranganath S., Asnagli H., Afkarian M., Murphy T.L. Signaling and transcription in T helper development. Annu. Rev. Immunol. 18:2000;451-494.
26. Nakajima H., Brindle P.K., Handa M., Ihle J.N. Functional interaction of STAT5 and nuclear receptor co-repressor SMRT. implications in negative regulation of STAT5-dependent transcription EMBO J. 20:2001;6836-6844.
27. Nelms K., Keegan A.D., Zamorano J., Ryan J.J., Paul W.E. The IL-4 receptor. signaling mechanisms and biologic functions Annu. Rev. Immunol. 17:1999;701-738.
28. Noben-Trauth N., Shultz L.D., Brombacher F., Urban J.F. Jr., Gu H., Paul W.E. An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice. Proc. Natl. Acad. Sci. USA. 94:1997;10838-10843.
29. Onishi M., Nosaka T., Misawa K., Mui A.L., Gorman D., McMahon M., Miyajima A., Kitamura T. Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol. Cell. Biol. 18:1998;3871-3879.
30. Ouyang W., Ranganath S.H., Weindel K., Bhattacharya D., Murphy T.L., Sha W.C., Murphy K.M. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity. 9:1998;745-755.
31. Ouyang W.J., Lohning M., Gao Z.G., Assenmacher M., Ranganath S., Radbruch A., Murphy K.M. Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity. 12:2000;27-37.
32. Siegel M.D., Zhang D.H., Ray P., Ray A. Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLE0 elements. J. Biol. Chem. 270:1995;24548-24555.
33. Solymar D.C., Agarwal S., Bassing C.H., Alt F.W., Rao A. A 3′ enhancer in the IL-4 gene regulates cytokine production by Th2 cells and mast cells. Immunity. 17:2002;41-50.
34. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 100:2000;655-669.
35. Szabo S.J., Sullivan B.M., Stemmann C., Satoskar A.R., Sleckman B.P., Glimcher L.H. Distinct effects of T-bet in TH1 lineage commitment and IFNgamma production in CD4 and CD8 T cells. Science. 295:2002;338-342.
36. Takemoto N., Kamogawa Y., Jun-Lee H., Kurata H., Arai K.I., O'Garra A., Arai N., Miyatake S. Cutting edge. chromatin remodeling at the IL-4/IL-13 intergenic regulatory region for Th2-specific cytokine gene cluster J. Immunol. 165:2000;6687-6691.
37. Yamashita M., Katsumata M., Iwashima M., Kimura M., Shimizu C., Kamata T., Shin T., Seki N., Suzuki S., Taniguchi M., Nakayama T. T cell receptor-induced calcineurin activation regulates T helper type 2 cell development by modifying the interleukin 4 receptor signaling complex. J. Exp. Med. 191:2000;1869-1879.
38. Yamashita M., Ukai-Tadenuma M., Kimura M., Omori M., Inami M., Taniguchi M., Nakayama T. Identification of a conserved GATA3 response element upstream proximal from the interleukin-13 gene locus. J. Biol. Chem. 277:2002;42399- 42408.
39. Zheng W., Flavell R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell. 89:1997;587-596.
40. Zhu M., John S., Berg M., Leonard W.J. Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNγ-mediated signaling. Cell. 96:1999;121-130.
41. Zhu J., Guo L., Watson C.J., Hu-Li J., Paul W.E. Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. J. Immunol. 166:2001;7276-7281.
42. Zhu J., Guo L., Min B., Watson C.J., Hu-Li J., Young H.A., Tsichlis P.N., Paul W.E. Growth factor independent-1 induced by IL-4 regulates Th2 cell proliferation. Immunity. 16:2002;733-744.